Condition: Cholera Vaccination · Sponsor: International Vaccine Institute
This Phase I/III clinical trial is intended to establish the immunogenicity and safety profile of Biovac OCV-S compared to available WHO pre-qualified vaccine Euvichol®-Plus in healthy adults and children and in adult people living with HIV (PLWH). The lot-to-lot consistency of Biovac OCV-S in healthy adults will also be determined.
This description comes directly from the study's public registry record.
Dr. Naveena D'Cor Project Technical Lead / Study Medical Monitor, MD · +82 2 8811 000 · naveena.dcor@ivi.int
Beverley Cowper Medical Consultant, MD · BeverleyC@biovac.co.za
Always discuss trial participation with your own doctor first.
| Synergy Biomed Research Institute | Durban, Eastern Cape, South Africa | Not Yet Recruiting |
| Perinatal HIV Research Unit (PHRU) | Johannesburg, Gauteng, South Africa | Recruiting |
| Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit | Johannesburg, Gauteng, South Africa | Not Yet Recruiting |
| SAMRC Chatworth CRS | Durban, KwaZulu-Natal, South Africa | Recruiting |
| SAMRC Isipingo CRS | Durban, KwaZulu-Natal, South Africa | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07304284